Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Evidence lags behind excitement over blood plasma as a coronavirus treatment

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Nature 584, 505 (2020)


Updates & Corrections

  • Update 24 August 2020: The US Food and Drug Administration issued an emergency-use authorization on 23 August to treat COVID-19 with convalescent plasma.


  1. Joyner, M. J. et al. J. Clin. Invest. (2020).

    Article  Google Scholar 

  2. Joyner, M. J. et al. Preprint at medRxiv (2020).

  3. Joyner, M. J. et al. Preprint at medRxiv (2020).

  4. Landray, M. J. et al. Preprint at medRxiv (2020).

Download references


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links